Geneos Wealth Management’s Schwab US Broad Market ETF SCHB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $943K | Hold |
32,553
| – | – | 0.02% | 559 |
|
|
2026
Q1 | $817K | Sell |
32,553
-1,542
| -5% | -$40.5K | 0.02% | 556 |
|
|
2025
Q4 | $894K | Buy |
34,095
+1,554
| +5% | +$40.5K | 0.02% | 526 |
|
|
2025
Q3 | $837K | Sell |
32,541
-1,259
| -4% | -$31.2K | 0.02% | 530 |
|
|
2025
Q2 | $805K | Sell |
33,800
-13,086
| -28% | -$288K | 0.02% | 588 |
|
|
2025
Q1 | $1.01M | Buy |
46,886
+45,067
| +2,478% | +$1.03M | 0.01% | 658 |
|
|
2024
Q4 | $41.3K | Sell |
1,819
-161
| -8% | -$3.68K | ﹤0.01% | 1394 |
|
|
2024
Q3 | $43.9K | Buy |
1,980
+45
| +2% | +$961 | ﹤0.01% | 1247 |
|
|
2024
Q2 | $40.5K | Buy |
1,935
+264
| +16% | +$5.35K | ﹤0.01% | 1140 |
|
|
2024
Q1 | $34K | Sell |
1,671
-3
| -0.2% | -$58 | ﹤0.01% | 1200 |
|
|
2023
Q4 | $31.1K | Buy |
1,674
+183
| +12% | +$3.16K | ﹤0.01% | 1221 |
|
|
2023
Q3 | $24.8K | Buy |
1,491
+6
| +0.4% | +$104 | ﹤0.01% | 1296 |
|
|
2023
Q2 | $25.6K | Buy |
1,485
+3
| +0.2% | +$49 | ﹤0.01% | 1290 |
|
|
2023
Q1 | $23.6K | Buy |
1,482
+60
| +4% | +$938 | ﹤0.01% | 1289 |
|
|
2022
Q4 | $21.2K | Buy |
1,422
+6
| +0.4% | +$90 | ﹤0.01% | 1325 |
|
|
2022
Q3 | $19K | Sell |
1,416
-138
| -9% | -$2.15K | ﹤0.01% | 1341 |
|
|
2022
Q2 | $23K | Buy |
1,554
+90
| +6% | +$1.45K | ﹤0.01% | 1631 |
|
|
2022
Q1 | $26K | Buy |
1,464
+6
| +0.4% | +$105 | ﹤0.01% | 1679 |
|
|
2021
Q4 | $27K | Buy |
1,458
+6
| +0.4% | +$110 | ﹤0.01% | 1734 |
|
|
2021
Q3 | $25K | Sell |
1,452
-10,338
| -88% | -$184K | ﹤0.01% | 1807 |
|
|
2021
Q2 | $207K | Sell |
11,790
-3,582
| -23% | -$60.6K | 0.01% | 823 |
|
|
2021
Q1 | $260K | Sell |
15,372
-1,110
| -7% | -$17.5K | 0.01% | 857 |
|
|
2020
Q4 | $212K | Buy |
16,482
+5,364
| +48% | +$76.4K | 0.01% | 804 |
|
|
2020
Q3 | $144K | Hold |
11,118
| – | – | 0.01% | 798 |
|
|
2020
Q2 | $132K | Sell |
11,118
-96
| -0.9% | -$1.11K | 0.01% | 801 |
|
|
2020
Q1 | $111K | Buy |
11,214
+10,422
| +1,316% | +$126K | 0.01% | 803 |
|
|
2019
Q4 | $10K | Hold |
792
| – | – | ﹤0.01% | 1983 |
|
|
2019
Q3 | $9K | Hold |
792
| – | – | ﹤0.01% | 1934 |
|
|
2019
Q2 | $9K | Sell |
792
-1,050
| -57% | -$12.1K | ﹤0.01% | 1945 |
|
|
2019
Q1 | $20K | Sell |
1,842
-84
| -4% | -$917 | ﹤0.01% | 1578 |
|
|
2018
Q4 | $19K | Hold |
1,926
| – | – | ﹤0.01% | 1527 |
|
|
2018
Q3 | $22K | Sell |
1,926
-210
| -10% | -$2.42K | ﹤0.01% | 1537 |
|
|
2018
Q2 | $23K | Hold |
2,136
| – | – | ﹤0.01% | 1393 |
|
|
2018
Q1 | $22K | Hold |
2,136
| – | – | ﹤0.01% | 1354 |
|
|
2017
Q4 | $22K | Hold |
2,136
| – | – | ﹤0.01% | 1347 |
|
|
2017
Q3 | $21K | Hold |
2,136
| – | – | ﹤0.01% | 1303 |
|
|
2017
Q2 | $20K | Buy |
2,136
+600
| +39% | +$5.79K | ﹤0.01% | 1284 |
|
|
2017
Q1 | $14K | Buy |
+1,536
| New | +$14.4K | ﹤0.01% | 1377 |
|
Other funds holding SCHB
R
SCM
SG
EK
HCM
Geneos Wealth Management's SCHB Position: Q2 2026 in Review
Geneos Wealth Management held its Schwab US Broad Market ETF (SCHB) position steady in Q2 2026 at 32,553 shares worth $943K. The position accounts for 0.02% of the portfolio, ranked #559.
Geneos Wealth Management first reported a position in SCHB in Q1 2017 and has held it in 38 quarters since. The position peaked at $1.01M in Q1 2025. 1,386 funds tracked by Wall St. Rank hold SCHB as of Q2 2026.
- Geneos Wealth Management held 32,553 shares of Schwab US Broad Market ETF worth $943K as of Q2 2026.
- Geneos Wealth Management left its Schwab US Broad Market ETF share count unchanged in Q2 2026.
- Schwab US Broad Market ETF made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #559 holding.
- Geneos Wealth Management first reported a position in Schwab US Broad Market ETF in Q1 2017 and has held it in 38 quarters since.
- Geneos Wealth Management's Schwab US Broad Market ETF position peaked at $1.01M in Q1 2025.
- 1,386 funds tracked by Wall St. Rank held Schwab US Broad Market ETF as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.